Search Results - "Modi S"

Neoadjuvant trastuzumab deruxtecan alone or followed by paclitaxel, trastuzumab, and pertuzumab for high-risk HER2-positive early breast cancer (DESTINY-Breast11): a randomised, open-label, multicentre, phase III trial.

Authors: Harbeck, N. Modi, S. Pusztai, L. et al.

Source: Annals of Oncology. Feb2026, Vol. 37 Issue 2, p166-179. 14p.

Reply to Letter to the Editor "The curious incident of the T-DXd alone arm killed at (DESTINY-Breast) eleven o'clock" by Orlandi.

Authors: Harbeck, N. Modi, S. Pusztai, L. et al.

Source: Annals of Oncology. Jul2026, Vol. 37 Issue 7, p1012-1013. 2p.

Permeability Spectral Analysis and Determination of Microstructural Parameters for Mn0.7+xZn0.3SixFe2-2xO4 Series.

Authors: Saija, K. G. Raval, P. Y. Joshi, N. P. et al.

Source: Journal of Superconductivity & Novel Magnetism; Dec2020, Vol. 33 Issue 12, p3827-3834, 8p

Trastuzumab deruxtecan in previously treated patients with HER2-positive metastatic breast cancer: updated survival results from a phase II trial (DESTINY-Breast01).

Authors: Saura, C. Modi, S. Krop, I. et al.

Source: Annals of Oncology. Mar2024, Vol. 35 Issue 3, p302-307. 6p.

This result is not displayed to guests.
Login for full access.

Alteration in intrinsic and extrinsic functional connectivity of resting state networks associated with subclinical hypothyroidism.

Authors: Kumar, M. Modi, S. Rana, P. et al.

Source: Journal of Neuroendocrinology. May2018, Vol. 30 Issue 5, p1-11. 11p.

291O DESTINY-Breast11: Neoadjuvant trastuzumab deruxtecan alone (T-DXd) or followed by paclitaxel + trastuzumab + pertuzumab (T-DXd-THP) vs SOC for high-risk HER2+ early breast cancer (eBC).

Authors: Harbeck, N. Modi, S. Pusztai, L. et al.

Source: Annals of Oncology. 2025 Supplement 2, Vol. 36, pS320-S321. 2p.

Is the radiopacity of CAD/CAM aesthetic materials sufficient?

Authors: Babaier, Rua S. Aldeeb, Modi S. Silikas, Nick et al.

Source: Dental Materials. Jun2022, Vol. 38 Issue 6, p1072-1081. 10p.

Subjects: Radiopacity, Dental materials, Digital images, Kruskal-Wallis Test, Aesthetics, Dental technology

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer.

Authors: Modi, S. Jacot, W. Yamashita, T. et al.

Source: New England Journal of Medicine. 7/7/2022, Vol. 387 Issue 1, p9-20. 12p.

Absence of clinical benefit of FDG PET-CT in staging T1 part-solid lung adenocarcinoma.

Authors: Pencharz, D. Modi, S. Bandyopadhyay, S. et al.

Source: Clinical Radiology. Mar2022, Vol. 77 Issue 3, p195-202. 8p.

The effect of targeted rheumatoid arthritis therapies on anti-citrullinated protein autoantibody levels and B cell responses.

Authors: Modi, S. Soejima, M. Levesque, M. C.

Source: Clinical & Experimental Immunology. Jul2013, Vol. 173 Issue 1, p8-17. 10p. 2 Diagrams, 3 Charts.

Use of a single-circuit CentriMag® for biventricular support in postpartum cardiomyopathy.

Authors: Aggarwal, A Modi, S Kumar, S et al.

Source: Perfusion. Mar2013, Vol. 28 Issue 2, p156-159. 4p. 2 Black and White Photographs, 1 Chart.

Voxel-Based Morphometric Analysis in Hypothyroidism Using Diffeomorphic Anatomic Registration via an Exponentiated Lie Algebra Algorithm Approach.

Authors: Singh, S. Modi, S. Bagga, D. et al.

Source: Journal of Neuroendocrinology. Mar2013, Vol. 25 Issue 3, p229-234. 6p. 2 Color Photographs, 4 Charts.

Pooled analysis by best confirmed response to trastuzumab deruxtecan and related biomarkers in patients with HER2-positive metastatic breast cancer from DESTINY-Breast01, DESTINY-Breast02, and DESTINY-Breast03.

Authors: Saura, C. Cortés, J. Modi, S. et al.

Source: Annals of Oncology. Mar2026, Vol. 37 Issue 3, p353-363. 11p.

621TiP BNT323-03: A phase I/II trial of BNT323/DB-1303 (HER2 ADC) with BNT327 (PD-L1 x VEGF-A) in patients (pts) with advanced breast cancer (BC).

Authors: Modi, S. Ates, O. Baird, R.D. et al.

Source: Annals of Oncology. 2025 Supplement 2, Vol. 36, pS465-S465. 1p.

Oxidation control in arc-sprayed SS420 coating.

Authors: Tailor, Satish Vashishtha, Nitesh Modi, Ankur et al.

Source: Surface Engineering; May2021, Vol. 37 Issue 5, p581-589, 9p

DNA-Dependent Synthesis of RNA Is Not Implicated in Growth Response of Chick Comb to Androgens.

Authors: TALWAR, G. P. MODI, S. RAO, K. N.

Source: Science (pre-March 2025). 12/3/1965, Vol. 150 Issue 3701, p1315-1316. 2p.